Similar articles

• Cyclosporine: a double-edged sword.

  Keown PA, Stiller CR. Keown PA, et al. Hosp Pract (Off Ed). 1987 May 15;22(5):207-15, 219-20. Hosp Pract (Off Ed). 1987. PMID: 3106374 No abstract available.
• Optimal cyclosporine plasma levels decline with time of therapy.

  Klintmalm G, Säwe J, von Bahr C, Ringdén O, Lundgren G, Wilczek H, Tydén G, Groth CG. Klintmalm G, et al. Transplant Proc. 1984 Oct;16(5):1208-11. Transplant Proc. 1984. PMID: 6385380
• Action and toxicity of cyclosporine.

  Bennett WM, Norman DJ. Bennett WM, et al. Annu Rev Med. 1986;37:215-24. doi: 10.1146/annurev.me.37.020186.001243. Annu Rev Med. 1986. PMID: 2939791 Review.
• Renal function and blood pressure in heart transplant recipients treated with cyclosporine.

  Rottembourg J, Mattei MF, Cabrol A, Leger P, Aupetit B, Beaufils H, Gluckman JC, Pavie A, Gandjbakhch I, Cabrol C. Rottembourg J, et al. J Heart Transplant. 1985 Jul-Aug;4(4):404-8. J Heart Transplant. 1985. PMID: 3916515
• Cyclosporine.

  Ptachcinski RJ, Burckart GJ, Venkataramanan R. Ptachcinski RJ, et al. Drug Intell Clin Pharm. 1985 Feb;19(2):90-100. doi: 10.1177/106002808501900202. Drug Intell Clin Pharm. 1985. PMID: 3882378 Review.